UC Berkeley Extension Announces Redesigned Post-Baccalaureate Health Professions Program

Academic-enhancer, career-changer tracks give students additional flexibility and increased access BERKELEY, Calif.–(BUSINESS WIRE)–#careeradvancement—UC Berkeley Extension is pleased to announce the launch of academic-enhancer and career-changer tracks for students interested in becoming competitive applicants to the health professions program of their dreams. The Post-Baccalaureate Health Professions Program provides opportunities for students to realize their educational and … [Read more…]

Sarepta Therapeutics Announces that the Date of the Advisory Committee Meeting for SRP-9001 will be May 12, 2023

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the date of the U.S. Food and Drug Administration’s Cellular, Tissue and Gene Therapies Advisory Committee meeting for the SRP-9001 (delandistrogene moxeparvovec) biologics license application (BLA) is May 12, 2023. The advisory committee meeting will be hosted … [Read more…]

MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting

FOSTER CITY, Calif.–(BUSINESS WIRE)–#AACR—MedGenome, a global precision medicine company specializing in omics solutions, today announced that it will be exhibiting at the American Association for Cancer Research Annual Meeting on April 14 – 19, 2023 in Orlando, Florida. MedGenome will be at Booth #2074 to exhibit its advanced single cell sequencing and immune repertoire profiling … [Read more…]

Priority OnDemand Announces Release of Inaugural ESG Report

KNOXVILLE, Tenn.–(BUSINESS WIRE)–Priority OnDemand (“the Company”), a national leader in medical transportation and mobile health solutions, announced today the release of its inaugural Environment, Social and Governance (ESG) Report, highlighting its initiatives and best practices to drive sustainable, equitable and governance best practices. “We are very proud to share our 2023 ESG report and to … [Read more…]

Tune Therapeutics Strengthens Leadership Team with Addition of Dr. Derek Jantz as Chief Scientific Officer and Zachary Hale as General Counsel

The genetic tuning innovator adds pioneering genetic medicine expert and an accomplished biotechnology lawyer to its management team. DURHAM, N.C. & SEATTLE–(BUSINESS WIRE)–Today, leading epigenomic editing company Tune Therapeutics introduced two members to its leadership team: Chief Scientific Officer, Derek Jantz, Ph.D., and General Counsel, Zachary Hale, J.D. Dr. Jantz comes to Tune with deep … [Read more…]

Cariloop Teams Up with Walgreens to Provide Dedicated Support to Those Living with Multiple Sclerosis

DALLAS–(BUSINESS WIRE)–Cariloop today announced those living with multiple sclerosis (MS) and their caregivers may now access its caregiver support services at select Walgreens neurology-specialty pharmacies. Cariloop’s platform for caregivers combines professional coaching services and cloud-based tools that help families plan for and manage every aspect of their caregiving journey. In this program, individuals with MS … [Read more…]

Walgreens Returns as the Exclusive Retail Partner of Red Nose Day to Help Ensure a Healthy Future for All Children and End Child Poverty

Following a record-breaking fundraising year in 2022, Walgreens nationwide are selling Red Noses and accepting in-store donations to support Red Nose Day 2023 DEERFIELD, Ill.–(BUSINESS WIRE)–Today, Walgreens nationwide kick off sales and in-store donations for the ninth annual Red Nose Day campaign to support healthy communities and help end the cycle of child poverty. Now … [Read more…]

New Phase 2 Data With Cretostimogene Grenadenorepvec (CG0070) in Combination with KEYTRUDA® (pembrolizumab) in BCG-Unresponsive NMIBC at the AUA 2023 Annual Meeting

IRVINE, Calif.–(BUSINESS WIRE)–#AUA2023—CG Oncology, Inc. today announced acceptance of an oral presentation at the American Urological Association (AUA) 2023 Annual Meeting in Chicago, IL from April 28-May 1, 2023. The updated data will be presented from the CORE-001 study, an ongoing Phase 2 clinical trial of cretostimogene grenadenorepvec (CG0070) in combination with Merck’s anti-PD-1 therapy … [Read more…]

Apnimed to Present at the 22nd Annual Needham Virtual Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea (OSA) and related disorders, including its lead oral treatment candidate AD109, today announced that Company management will present and host one-on-one investor meetings at the 22nd Needham Healthcare Conference taking place virtually April 17-20, … [Read more…]